candesartan has been researched along with Peritoneal Carcinomatosis in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effects of AT1 receptor blocker candesartan were evaluated in a mouse model of peritoneal carcinomatosis." | 3.75 | Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin. ( Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Ohta, T; Yagi, Y; Yashiro, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, J | 1 |
| Fushida, S | 1 |
| Harada, S | 1 |
| Yagi, Y | 1 |
| Fujita, H | 1 |
| Kinami, S | 1 |
| Ninomiya, I | 1 |
| Fujimura, T | 1 |
| Kayahara, M | 1 |
| Yashiro, M | 1 |
| Hirakawa, K | 1 |
| Ohta, T | 1 |
1 other study available for candesartan and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Angiotensin II; A | 2009 |